01 AI-Powered Stone Detection Improves Diagnostic Accuracy and Treatment Planning The growing need for precise stone identification and effective surgical planning is encouraging the adoption of AI-assisted imaging systems that detect, classify, and measure kidney stones during minimally invasive procedures, supporting market demand for advanced diagnostic technologies. In November 2025, a study published in npj Digital Medicine evaluated an AI-assisted flexible ureteroscopy system that achieved 92.2%–95.3% diagnostic accuracy in a 100-case clinical validation, while external validation across 80 cases produced accuracy rates of 86.8%–92.2% for different stone types. These capabilities can help urologists assess stone characteristics and residual fragments during surgery, supporting more informed treatment decisions and strengthening the role of AI in kidney stone care.
02 Thulium Fiber Laser Technology Advances Minimally Invasive Stone Removal The need for effective stone fragmentation with reduced procedural burden is encouraging the adoption of thulium fiber laser technology in minimally invasive kidney stone treatment. The European Association of Urology’s urolithiasis guidelines recognize thulium fiber lasers as an established option for ureteroscopy, with evidence indicating clinical outcomes comparable to holmium:YAG lasers, although superiority is not conclusively established. Continued refinement of laser systems can expand treatment options for urologists and support market growth as hospitals and specialist centers adopt advanced technologies for endoscopic stone management.
01 Rising Kidney Stone Incidence and Expanding Urology Treatment Capacity Drive Kidney Stone Market Growth The growing burden of kidney stones increases demand for diagnostic services, medications, and procedures that support effective stone management. Recurrent stone formation and complications such as urinary obstruction can lead to repeated hospital visits and a greater need for urological care. These clinical requirements support demand for imaging systems, ureteroscopes, and treatments such as extracorporeal shock wave lithotripsy. For example, patients with ureteral stones may require ureteroscopy to remove stones and restore urine flow, supporting market demand for kidney stone treatment technologies.Greater investment in urology departments and specialized treatment centers increases the availability of services for patients with kidney stones. Hospitals require endoscopic instruments, lithotripsy systems, and related surgical equipment to manage stones of different sizes and locations. Improved access to these facilities allows more patients to receive appropriate interventions, while creating procurement opportunities for medical device manufacturers. For example, hospitals establishing endourology services may invest in flexible ureteroscopes and laser lithotripsy equipment, supporting market expansion across the healthcare sector.
01 Treatment-Related Risks and Shortages of Urological Specialists Constrain Kidney Stone Market Adoption The risk of bleeding, infection, and injury to the urinary tract can make patients and healthcare providers cautious about invasive kidney stone treatments. Potential complications may require additional monitoring, follow-up procedures, or longer recovery periods, increasing the overall burden of treatment. These concerns can encourage eligible patients to postpone interventions or prefer conservative management when clinically appropriate. Such hesitation can restrict market adoption of certain surgical and device-based treatment options.The limited availability of trained urologists and professionals skilled in advanced stone-removal procedures can restrict access to specialized kidney stone care. Hospitals in underserved and rural areas may lack the expertise required to operate advanced endoscopic and laser-based systems, limiting the range of treatments they can offer. Patients may need referrals to larger medical centers, resulting in delays and additional travel costs. These access barriers can slow market penetration of advanced treatment technologies, particularly in regions with limited specialist capacity.
01 Personalized Prevention Services and Digital Stone Analysis Create New Kidney Stone Market Opportunities Diagnostic laboratories and kidney care providers can expand into personalized stone prevention through metabolic assessments that identify individual risk factors for recurring kidney stones. At-home urine testing and tailored clinical reports allow providers to extend services beyond the initial diagnosis and treatment episode. Labcorp’s Litholink service offers 24-hour urine testing with patient-specific results and treatment guidance, demonstrating an established commercial model for this approach. Repeat testing, laboratory partnerships, and follow-up services create revenue opportunities for diagnostic providers and specialized kidney care businesses.Medical technology companies can develop software that analyzes diagnostic images to support stone measurement, treatment planning, and post-procedure monitoring. Automated image analysis can help clinicians assess stone size and location, while digital follow-up tools can support the tracking of residual fragments and recurrence. Healthcare software vendors can generate revenue through hospital licensing, imaging-system integration, and subscription-based clinical tools. These solutions can strengthen market differentiation for providers offering connected diagnostic and treatment-planning technologies.
April 2026 Olympus Corporation strengthened its urology portfolio by launching enhanced digital ureteroscopes and stone retrieval devices to support minimally invasive treatment of kidney stones.
February 2026 Dornier MedTech expanded its lithotripsy solutions by introducing advanced extracorporeal shock wave lithotripsy (ESWL) systems featuring improved imaging guidance and treatment precision.
September 2025 Cook Medical introduced upgraded stone extraction devices and urological access products designed to enhance procedural efficiency and improve patient outcomes during kidney stone treatment.
May 2025 Coloplast strengthened its urology portfolio by expanding products supporting kidney stone management and postoperative urinary care, reinforcing its presence in minimally invasive urological procedures.